Seeking Alpha

Salix Pharmaceuticals (SLXP): Q3 EPS of $0.95 beats by $0.25. Revenue of $185.1M (+26.6% Y/Y)...

Salix Pharmaceuticals (SLXP): Q3 EPS of $0.95 beats by $0.25. Revenue of $185.1M (+26.6% Y/Y) misses by $2M. Shares +8.4% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)